How Do Older Adults Consider Age, Life Expectancy, Quality of Life, and Physician Recommendations When Making Cancer Screening Decisions? Results from a National Survey Using a Discrete Choice Experiment

Ellen M. Janssen, Craig E. Pollack, Cynthia Boyd, John F. P. Bridges, Qian-Li Xue, Antonio C. Wolff and Nancy L. Schoenborn
Additional contact information
Ellen M. Janssen: Department of Health Policy and Management, Johns Hopkins School of Public Health, Baltimore, MD, USA
Craig E. Pollack: The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Cynthia Boyd: The Johns Hopkins University School of Medicine, Baltimore, MD, USA
John F. P. Bridges: The Ohio State University, Columbus, OH, USA
Qian-Li Xue: The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Antonio C. Wolff: The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Nancy L. Schoenborn: The Johns Hopkins University School of Medicine, Baltimore, MD, USA

Medical Decision Making, 2019, vol. 39, issue 6, 621-631

Abstract: Background. Older adults with limited life expectancy frequently receive cancer screening, although on average, harms outweigh benefits. We examined the influence of life expectancy on older adults’ cancer screening decisions relative to three other factors. Methods. Adults aged 65+ years ( N = 1272) were recruited from a national online survey panel. Using a discrete choice experiment, we systematically varied a hypothetical patient’s life expectancy, age, quality of life, and physician’s recommendation and asked whether the participant would choose screening. Participants were randomized to questions about colonoscopy or prostate-specific antigen/mammography screenings. Logistic regression produced preference weights that quantified the relative influence of the 4 factors on screening decisions. Results. 879 older adults completed the survey, 660 of whom varied their screening choices in response to the 4 factors we tested. The age of the hypothetical patient had the largest influence on choosing screening: the effect of age being 65 versus 85 years had a preference weight of 2.44 (95% confidence interval [CI]: 2.22, 2.65). Life expectancy (10 versus 1 year) had the second largest influence (preference weight: 1.64, CI: 1.41, 1.87). Physician recommendation (screen versus do not screen) and quality of life (good versus poor) were less influential, with preference weights of 0.90 (CI: 0.72, 1.08) and 0.68 (CI: 0.52, 0.83), respectively. Conclusions. While clinical practice guidelines increasingly use life expectancy in addition to age to guide screening decisions, we find that age is the most influential factor, independent of life expectancy, quality of life, and physician recommendation, in older adults’ cancer screening choices. Strategies to reduce overscreening should consider the importance patients give to continuing screening at younger ages, even when life expectancy is limited.

Keywords: cancer screening; decision making; discrete choice experiment; older adults; patient preferences (search for similar items in EconPapers)
Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X19853516 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:39:y:2019:i:6:p:621-631

DOI: 10.1177/0272989X19853516

Access Statistics for this article

More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().